Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

DualNet: a Deep Neural Network to Predict Individual Tau and Amyloid PET Images from a Combined Dose Image using the Disambiguation of Dual Dose Amyloid-Tau PET Scans Using The ADNI Dataset

Todd Macdonald, Kevin Chen, Mary Ellen Koran, Michael Moseley and Greg Zaharchuk
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 3009;
Todd Macdonald
1Stanford University Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Chen
1Stanford University Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Ellen Koran
1Stanford University Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Moseley
2Stanford University School of Medicine Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg Zaharchuk
1Stanford University Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

3009

Objectives: The medical community currently does not have a reliable gold standard to diagnose Alzheimer’s Disease (AD), nor an exact understanding of its cause. As a result, multiple different brain tracers are commonly used. Since amyloid and tau tracers measure different molecular changes associated withAD, it is helpful to measure both of these predisposing factors for an informed AD diagnosis. However, this requires scheduling multiple imaging sessions, which is costly and may be difficult for the participants. Therefore, we explored whether it might be possible to inject both tracers simultaneously and use deep learning to “disentangle” them to produce separate “pure” amyloid and tau images, similar to identifying different speakers in a crowded room (so-called “cocktail party problem”). In this study, we demonstrate a deep learning approach called DualNet to predict separate amyloid and tau PET scans from a combined dual-tracer image that is simulated from scans within the ADNI database.

Methods: From ADNI, we identified 482 pairs of normalized amyloid (AV-45) and tau (AV-1451) scans (264/133/37/6/42 scans for CDR score breakdown 0/0.5/1/2/unknown). Each tau-amyloid pair represents a unique patient, and the amyloid and tau scans selected per patient are the closest in time to one another out of all relevant scans for that patient. The input data to the model is the summation of amyloid and tau scans, and the output is the separate amyloid and tau scans. Since the tau and amyloid scans are not acquired concurrently, we account for this fact by using the co-registered, standard-voxel size images available in ADNI, and normalizing the sum of voxel values to 1. For the DualNet model, we use an architecture that follows the general residual UNet structure, as introduced in Chen et al.’s RED-CNN, except that it makes use of a VGG-11 encoder that is pre-trained on ImageNet, similar to Iglovikov et al.’s TernausNet. We also make use of Oktay et al.’s attention gate mechanisms for our residual connections, while removing the batchnorm layer present in Oktay et al.’s original implementation. Lastly, to simulate possible imbalances between amyloid and tau counts during PET acquisition, we experiment with training our model to handle 1:1, 1:3, and 3:1 ratios of amyloid to tau in the combined dual dose scan. To compare models, we used a baseline estimate that the amyloid and tau images are present in proportion to the overall number of counts, and assessed quality using the mean absolute (L1 loss) and mean square error (MSE).

Results: Overall, DualNet performs significantly better than the baseline model, with 44% and 71% reductions L1 and MSE loss, as well as a 32% increase in PSNR. Furthermore, from a qualitative perspective, the vast majority of predicted scans are visibly indistinguishable from the true amyloid and tau scans. However, in patients with a higher CDR score, the class-imbalanced model does not perform as well as in the average case. In patients with a (CDR ) score of 2.0, the model performs the worst, with the average L1 loss for amyloid and tau scans being 33% higher than the overall dataset and only improved by 28% when compared with the baseline.

Conclusions: On average, starting from a combined amyloid-tau image, the DualNet deep learning method can produce separate amyloid and tau scans that show a marked improvement over the baseline model, with high qualitative assessments. Future work will include clinical assessment of the predicted scans along with quantitative SUVR measurements, as well as more realistic simulations of the combined images using acquired list-mode data for each tracer. Overall, the method offers the potential to simplify the molecular imaging commonly done in AD, reducing costs as well as patient burden, and as such may be helpful for both clinical assessment and drug trials.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
DualNet: a Deep Neural Network to Predict Individual Tau and Amyloid PET Images from a Combined Dose Image using the Disambiguation of Dual Dose Amyloid-Tau PET Scans Using The ADNI Dataset
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
DualNet: a Deep Neural Network to Predict Individual Tau and Amyloid PET Images from a Combined Dose Image using the Disambiguation of Dual Dose Amyloid-Tau PET Scans Using The ADNI Dataset
Todd Macdonald, Kevin Chen, Mary Ellen Koran, Michael Moseley, Greg Zaharchuk
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 3009;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
DualNet: a Deep Neural Network to Predict Individual Tau and Amyloid PET Images from a Combined Dose Image using the Disambiguation of Dual Dose Amyloid-Tau PET Scans Using The ADNI Dataset
Todd Macdonald, Kevin Chen, Mary Ellen Koran, Michael Moseley, Greg Zaharchuk
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 3009;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of Manual and Computer-Generated Methods for Segmentation of the Aorta in Lymphoma Patients from PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
Show more

Tech Papers II: Clinical PET Technologist Papers

  • Determining optimal uptake time for 68Ga-labeled radiopharmaceuticals targeting gastrin-releasing peptide receptors with a modified NEMA phantom.
  • Key components of a successful PET/MR department
  • Evaluation of Regularized Expectation Maximization Reconstruction on 68Ga PSMA PET
Show more Tech Papers II: Clinical PET Technologist Papers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire